Acute serum calcium changes in transient ischemic attack and cerebral infarction

It was already known that serum calcium levels can vary in response to acute medical conditions. However, no prior work had resolved whether these changes are specific to cerebral ischemia. Researchers have observed that calcium plays a role in cellular signaling and may be affected by tissue hypoxia. The mechanisms linking calcium levels to stroke severity remain unclear. Previous studies have not directly compared transient ischemic attack and cerebral infarction in this context. The clinical significance of acute calcium changes in these conditions is not well established. Some evidence suggests that hypocalcemia may be associated with poor outcomes in critical illness. This gap motivated a closer examination of calcium levels in patients with cerebral ischemia.

The researchers aimed to investigate whether serum calcium levels change in patients with transient ischemic attack or cerebral infarction. They wanted to determine if these changes differ between the two conditions and healthy controls. The study focused on total, albumin-corrected, and ionized calcium levels. They sought to assess the prognostic value of these measurements. The motivation was to clarify whether hypocalcemia is a marker of disease severity. They also aimed to distinguish between primary and secondary causes of calcium changes. The researchers intended to evaluate the relationship between calcium levels and in-hospital mortality. This approach could help identify a potential biomarker for cerebral ischemia.

The study measured total, albumin-corrected, and ionized calcium levels in patients with transient ischemic attack and cerebral infarction. These measurements were compared against values from healthy controls. Researchers used analysis of variance to assess differences between groups. They categorized patients based on outcomes, such as in-hospital mortality. The sample included individuals in the acute phase of their condition. Blood samples were collected within a defined time window after symptom onset. Researchers controlled for confounding factors like albumin levels. They evaluated the statistical significance of calcium changes across groups.

The study found that total calcium levels were significantly lower in cerebral infarction compared to transient ischemic attack and controls. Albumin-corrected and ionized calcium also showed significant decreases in infarction. The differences between groups were statistically significant (p < 0.0001 for total calcium). Patients who died in the hospital had lower total calcium than survivors (p < 0.005). Albumin-corrected and ionized calcium did not differ between survivors and non-survivors. The magnitude of calcium decrease correlated with the severity of cerebral ischemia. No significant differences were found in calcium levels between transient ischemic attack and controls. The results suggest that calcium changes are more pronounced in cerebral infarction than in transient ischemic attack.

The findings suggest that cerebral ischemia is associated with acute decreases in serum calcium levels. The most substantial changes were observed in patients with cerebral infarction. The relationship between calcium levels and disease severity appears to be significant. The cause of hypocalcemia remains uncertain in this context. The researchers propose that it may be a primary effect or a secondary phenomenon. The in-hospital mortality risk does not appear to be linked to albumin-corrected or ionized calcium. The study highlights the need for further research into the mechanisms of hypocalcemia. These results provide a basis for future investigations into calcium as a potential biomarker.